These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 29497837

  • 1. Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study'.
    Iglicki M, Zur D, Busch C, Okada M, Loewenstein A.
    Acta Diabetol; 2018 Jun; 55(6):541-547. PubMed ID: 29497837
    [Abstract] [Full Text] [Related]

  • 2. Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy.
    Wykoff CC, Chakravarthy U, Campochiaro PA, Bailey C, Green K, Cunha-Vaz J.
    Ophthalmology; 2017 Apr; 124(4):440-449. PubMed ID: 28081945
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trials.
    Danis RP, Sadda S, Li XY, Cui H, Hashad Y, Whitcup SM.
    Br J Ophthalmol; 2016 Jun; 100(6):796-801. PubMed ID: 26581718
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH.
    Invest Ophthalmol Vis Sci; 2013 May 09; 54(5):3378-84. PubMed ID: 23611988
    [Abstract] [Full Text] [Related]

  • 8. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.
    Busch C, Zur D, Fraser-Bell S, Laíns I, Santos AR, Lupidi M, Cagini C, Gabrielle PH, Couturier A, Mané-Tauty V, Giancipoli E, Ricci GD, Cebeci Z, Rodríguez-Valdés PJ, Chaikitmongkol V, Amphornphruet A, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Iglicki M, Rehak M, International Retina Group.
    Acta Diabetol; 2018 Aug 09; 55(8):789-796. PubMed ID: 29730822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS, Domalpally A, Sun JK, Ehrlich JS.
    Ophthalmology; 2015 Feb 09; 122(2):367-74. PubMed ID: 25439595
    [Abstract] [Full Text] [Related]

  • 11. TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY.
    Iglicki M, Zur D, Fung A, Gabrielle PH, Lupidi M, Santos R, Busch C, Rehak M, Cebeci Z, Charles M, Masarwa D, Schwarz S, Barak A, Loewenstein A, International Retina Group (IRG).
    Acta Diabetol; 2019 Oct 09; 56(10):1141-1147. PubMed ID: 31089929
    [Abstract] [Full Text] [Related]

  • 12. Baseline SD-OCT characteristics of diabetic macular oedema patterns can predict morphological features and timing of recurrence in patients treated with dexamethasone intravitreal implants.
    Eandi CM, De Geronimo D, Giannini D, Polito MS, Tosi GM, Neri G, Le Mer Y, Varano M, Parravano M.
    Acta Diabetol; 2020 Jul 09; 57(7):867-874. PubMed ID: 32114643
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R, Battaglia Parodi M, Casati S, Lattanzio R, Marchini G, Bandello F.
    Ophthalmic Res; 2017 Jul 09; 58(3):125-130. PubMed ID: 28704825
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ, Kuppermann BD, Lanzetta P, Loewenstein A, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MEAD Study Group.
    BMC Ophthalmol; 2015 Oct 30; 15():150. PubMed ID: 26519345
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
    Bandello F, Corvi F, La Spina C, Benatti L, Querques L, Capuano V, Naysan J, Chen X, Sarraf D, Parodi MB, Souied E, Freund KB, Querques G.
    Br J Ophthalmol; 2016 Dec 30; 100(12):1611-1616. PubMed ID: 26951773
    [Abstract] [Full Text] [Related]

  • 18. Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study.
    Querques L, Parravano M, Sacconi R, Rabiolo A, Bandello F, Querques G.
    Acta Diabetol; 2017 Aug 30; 54(8):769-773. PubMed ID: 28577137
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.